Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction Assay-Reference-Cited by-同舟云学术

Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction Assay

Published:1996-09-20 Issue:14 Volume:12 Page:1319-1328
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

MASCOLA JOHN R.,LOUDER MARK K.,SURMAN SONJA R.,VANCOTT THOMAS C.,YU XIAO FANG,BRADAC JAMES,PORTER KEVIN R.,NELSON KENRAD E.,GIRARD MARC,McNEIL JOHN G.,McCUTCHAN FRANCINE E.,BIRX DEBORAH L.,BURKE DONALD S.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1996.12.1319

Reference36 articles.

1. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes

2. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin

3. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

4. Genetic and Phylogenetic Analysis of env Subtypes G and H in Central Africa

5. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG;Virology Journal;2024-06-29

2. Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India;Journal of General Virology;2017-07-01

3. Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals;Microbes and Infection;2016-05

4. Prospects for a Globally Effective HIV-1 Vaccine;American Journal of Preventive Medicine;2015-12

5. Prospects for a globally effective HIV-1 vaccine;Vaccine;2015-11